{
    "2018-03-05": [
        [
            {
                "time": "2018-03-06",
                "original_text": "BlackRock, Inc. (BLK) Ex-Dividend Date Scheduled for March 06, 2018",
                "features": {
                    "keywords": [
                        "BlackRock",
                        "Ex-Dividend",
                        "Date",
                        "Scheduled"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "finance"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-03-06",
                "original_text": "Greenhill & Co., Inc. (GHL) Ex-Dividend Date Scheduled for March 06, 2018",
                "features": {
                    "keywords": [
                        "Greenhill",
                        "Ex-Dividend",
                        "Date",
                        "Scheduled"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "finance"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-02-01",
                "original_text": "Here's Why Celgene Corporation Fell in February",
                "features": {
                    "keywords": [
                        "Celgene",
                        "Corporation",
                        "Fell",
                        "February"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-01-01",
                "original_text": "What James Gorman Had to Say About the Future of Morgan Stanley",
                "features": {
                    "keywords": [
                        "James",
                        "Gorman",
                        "Morgan",
                        "Stanley",
                        "Future"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "finance"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-01-01",
                "original_text": "What Wall Street Has to Say about Charles Schwab",
                "features": {
                    "keywords": [
                        "Wall",
                        "Street",
                        "Charles",
                        "Schwab"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "finance"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-01-01",
                "original_text": "Analyzing Charles Schwabâ€™s Premium Valuations",
                "features": {
                    "keywords": [
                        "Charles",
                        "Schwab",
                        "Premium",
                        "Valuations"
                    ],
                    "sentiment_score": 0.3,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "finance"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-01",
                "original_text": "HSBC Poaches Morgan Stanley's Top Indonesia Dealmaker",
                "features": {
                    "keywords": [
                        "HSBC",
                        "Morgan",
                        "Stanley",
                        "Indonesia",
                        "Dealmaker"
                    ],
                    "sentiment_score": 0.2,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "finance"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}